SureTrader SureTrader Nadex Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 2/19/2017 10:57:24 AM - Followers: 1320 - Board type: Free - Posts Today: 3

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#209217  Sticky Note MNTA—I take it that it is not feasible DewDiligence 02/18/17 04:17:47 PM
#209204  Sticky Note Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted jq1234 02/17/17 06:13:18 PM
#209177  Sticky Note Celgene Corporation (CELG) today announced that its phase jbog 02/17/17 07:45:17 AM
#209175  Sticky Note SMMT @ BioCEO mcbio 02/16/17 10:49:48 PM
#209168  Sticky Note HCV may increase risk of non-HCC cancers: DewDiligence 02/16/17 07:15:48 PM
#209158  Sticky Note ONCE > ruminations on one-shot cures vs. insurer biocqr 02/16/17 03:37:30 PM
#209234   Any updates or thoughts on CASI Pharm. Gronk23 02/19/17 10:57:24 AM
#209233   For those interested in $VCEL's FDA MACI BLA lasers 02/19/17 08:53:44 AM
#209232   $VCEL's 1st MACI Surgery PR Feb 1, 2017 lasers 02/19/17 08:18:14 AM
#209231   That was based on only 50-60 patients per arm. jq1234 02/18/17 11:18:26 PM
#209230   That ignored independent study testing 4 different assays jq1234 02/18/17 11:17:34 PM
#209229   No, not even stat sig for PD-L1-positive subgroup. guerlain 02/18/17 10:54:22 PM
#209228   While it seems Roche & BMY/MRK started off JohnWayne 02/18/17 09:16:21 PM
#209227   $VCEL follow through Clinical Trial results for its lasers 02/18/17 07:36:38 PM
#209226   This is the $VCEL Clinical Trial that we lasers 02/18/17 07:22:21 PM
#209225   I can't say for class because no data jq1234 02/18/17 07:07:13 PM
#209224   Are you saying that IC is a better DewDiligence 02/18/17 07:01:34 PM
#209223   None of the other 3 gave any data jq1234 02/18/17 06:57:50 PM
#209222   Roche…stated PD-L1 expression on tumor infiltrating immune DewDiligence 02/18/17 06:51:54 PM
#209221   >> PD-L1-positive subgroup was defined as patients with jq1234 02/18/17 06:40:20 PM
#209220   Perhaps you and your group are interested in lasers 02/18/17 06:03:33 PM
#209219   Roche—Tecentriq/Avastin shows statisg-better PFS vs Sutent monotherapy in DewDiligence 02/18/17 05:59:27 PM
#209218   It's a reasonable question for 'zipjet' to ask, DewDiligence 02/18/17 04:20:15 PM
#209217   MNTA—I take it that it is not feasible DewDiligence 02/18/17 04:17:47 PM
#209214   I take it that it is not feasible vinmantoo 02/18/17 01:22:29 PM
#209213   That idea is ripped off from a Forbes DewDiligence 02/18/17 11:46:09 AM
#209211   I take it that it is not feasible zipjet 02/18/17 07:50:44 AM
#209210   Why This Billionaire Just Shelled Out $1.1 Billion Titan V 02/17/17 10:51:43 PM
#209209   rsv vaccines in development dangerM 02/17/17 08:39:40 PM
#209208   Why President Trump Should Buy Gilead Sciences https://www.fool.com/investing/2 Titan V 02/17/17 08:24:38 PM
#209207   MNTA 2017-2018 news flow (updated for delay to DewDiligence 02/17/17 06:58:10 PM
#209206   Bad timing on the MNTA news-flow post, LOL. DewDiligence 02/17/17 06:43:22 PM
#209205   GILD offloads a PhII-ready addiction therapy to an Titan V 02/17/17 06:14:23 PM
#209204   Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted jq1234 02/17/17 06:13:18 PM
#209203   Biotech 2017: 4 Ideas for A Stockpicker’s Year Titan V 02/17/17 06:09:55 PM
#209202   Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma http://ww Titan V 02/17/17 05:59:47 PM
#209201   I don't have an educated opinion on EVOK. zipjet 02/17/17 04:53:25 PM
#209199   I don't have an educated opinion on EVOK. DewDiligence 02/17/17 04:47:41 PM
#209198   Dew, What are your thoughts on EVOK? Mkt opp zumantu 02/17/17 03:11:20 PM
#209197   ENTA - The difficulty in developing RSV therapeutics mcbio 02/17/17 02:05:41 PM
#209196   Thanks guys runncoach 02/17/17 02:04:46 PM
#209195   Anavex (AVXL) in Alzheimer from Journal of Clinical Investigation DFRAI 02/17/17 01:58:32 PM
#209194   Why not Anavex - AVXL in AD DFRAI 02/17/17 01:24:29 PM
#209193   $OWCP up ~25% today (so far) after it FELLER 02/17/17 12:50:48 PM
#209192   #msg-128722661 has an overview of the leading drug DewDiligence 02/17/17 12:43:52 PM
#209191   The difficulty in developing RSV therapeutics (as opposed DewDiligence 02/17/17 12:40:27 PM
#209190   Here is a different take on Alzheimers that scott2987 02/17/17 12:28:37 PM
#209189   New ENTA slide set: Is there a specific mcbio 02/17/17 12:22:16 PM
#209188   Thanks. Fine exclusions IMO. The Broad anotherbiotechguy 02/17/17 12:00:35 PM
#209187   (CLLS/DD)—MON’s new CRISPR license has notable exclusions: DewDiligence 02/17/17 11:44:48 AM
#209186   looks like the folks who did promo work OakesCS 02/17/17 11:42:50 AM
#209184   Addendum re drug imports from Canada... DewDiligence 02/17/17 11:14:28 AM
#209183   AZN +1.5% on phase-3 Lynparza data in BRCA+ DewDiligence 02/17/17 10:46:32 AM
#209182   ABBV authorizes new $5B buyback: DewDiligence 02/17/17 10:13:01 AM
#209181   EVOK sold 2.78M* shares yesterday @$2.90—a 15% discount DewDiligence 02/17/17 10:03:19 AM
#209180   Don't know about contrarian, but I don't hear zipjet 02/17/17 09:57:19 AM
PostSubject